Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Needle-track metastasis in diffuse intrinsic pontine glioma: Need for a standardized surgical strategy?

Neuro-oncology advances·2026
Same author

Incomplete tumor resection, central neuroradiological review, and second surgery in pediatric patients with intracranial ependymoma treated in the E-HIT2000 trial.

Journal of neurosurgery. Pediatrics·2026
Same author

Cross-contamination of commercial oligonucleotides with library-structured sequences.

Nucleic acids research·2026
Same author

The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and Switzerland.

Pediatric blood & cancer·2026
Same author

Pediatric high-grade gliomas in patients with neurofibromatosis type 1-A collaborative cohort study from the SIOPE HGG/DIPG working group.

Neuro-oncology practice·2026
Same author

A Cre-mediated copy number variant compromises the reliability of a <i>LoxP-STOP-LoxP</i>-<i>PLAG1</i> driven brain tumor model.

Neuro-oncology advances·2026

Related Experiment Video

Updated: May 20, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

Dissecting the genomic complexity underlying medulloblastoma.

David T W Jones1, Natalie Jäger, Marcel Kool

  • 1Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, Heidelberg 69120, Germany.

Nature
|July 27, 2012
PubMed
Summary

This study identifies new genetic drivers in medulloblastoma, particularly in challenging Group 3 and 4 pediatric brain tumors. Findings offer potential new therapeutic targets for aggressive medulloblastoma cases.

More Related Videos

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

Revealing the Ferroptotic Phenotype of Medulloblastoma
04:01

Revealing the Ferroptotic Phenotype of Medulloblastoma

Published on: March 15, 2024

Related Experiment Videos

Last Updated: May 20, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

Revealing the Ferroptotic Phenotype of Medulloblastoma
04:01

Revealing the Ferroptotic Phenotype of Medulloblastoma

Published on: March 15, 2024

Area of Science:

  • Genomics
  • Pediatric Oncology
  • Molecular Biology

Background:

  • Medulloblastoma is the most common malignant pediatric brain tumor, characterized by significant heterogeneity.
  • Current treatments face challenges with recurrence and long-term quality of life, especially for Group 3 and 4 subtypes.
  • The precise genetic underpinnings of medulloblastoma, particularly Group 3 and 4, remain incompletely understood.

Purpose of the Study:

  • To conduct an integrative deep-sequencing analysis of medulloblastoma.
  • To identify novel genetic alterations and subgroup-specific mutations.
  • To uncover potential therapeutic targets for medulloblastoma, focusing on Group 3 and 4.

Main Methods:

  • Integrative deep-sequencing analysis of 125 medulloblastoma tumor-normal pairs.
  • Utilized RNA sequencing to identify gene fusions.
  • Analyzed genomic data within the context of the International Cancer Genome Consortium (ICGC) PedBrain Tumor Project.

Main Results:

  • Tetraploidy identified as a frequent early event in Group 3 and 4 medulloblastoma.
  • Discovered recurrent mutations in known and novel medulloblastoma-related genes (e.g., DDX3X, CTDNEP1, KDM6A, TBR1).
  • Identified the first medulloblastoma fusion genes and frequent alterations in chromatin modifiers across subgroups.

Conclusions:

  • Genomic complexity and heterogeneity in medulloblastoma are further elucidated.
  • New potential therapeutic targets identified, especially for high-risk Group 3 and 4 pediatric brain tumors.
  • Findings advance understanding of medulloblastoma pathogenesis and pave the way for targeted therapies.